AdvanSix Inc logo

AdvanSix Inc(ASIX)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$12.86
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ASIX

11/20/2026: ASIX (1-star) is currently NOT-A-BUY. Pass it for now.

AdvanSix Inc is a specialty chemical and plant nutrient company that operates integrated manufacturing facilities producing essential materials like nylon, caprolactam, and ammonium sulfate. The company's key strengths lie in its low-cost manufacturing scale at primary sites and strong North American market positioning. Its primary growth opportunity centers on expanding into higher-margin specialty chemicals through targeted acquisitions and product mix optimization. However, the company faces risks from volatile raw material feedstock costs, cyclical end-market demand, and intense global competition. AdvanSix serves as a potential fit for value-oriented investors willing to navigate cyclical chemical earnings while monitoring input costs and capital allocation strategies.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitAdvanSix operates in a cyclical chemical market characterized by moderate long-term organic growth rather than rapid secular expansion.
Momentum investorStrong fit while signal remains positiveMomentum fit depends on favorable chemical pricing cycles and positive earnings revisions driving short-term price breakouts.
Value investorStrong fitThe stock often trades at low price-to-sales and normalized price-to-earnings multiples relative to broader market averages, appealing to deep-value buyers.
Dividend investorMixed fitWhile the company pays a steady dividend, payouts can fluctuate given the cyclical nature of its underlying chemical cash flows.
Low-risk investorWeak fitEarnings volatility tied to commodity input costs and economic cycles introduce notable share price fluctuations.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highCommodity chemical pricing cycles and feedstock swings drive noticeable share price variance.
Valuation riskMediumLow valuation multiples help buffer downside risk, but prolonged cyclical downturns can compress earnings further.
Competition risk (global chemical and fertilizer commoditization)Medium / highGlobal supply dynamics and low-cost international competitors can pressure profit margins.
Business qualityMediumIntegrated single-site assets provide cost advantages, though cyclical exposure prevents top-tier franchise status.
Dividend incomeMediumRegular dividend payouts provide income, but sustainability depends on cash flow generation across cycles.
Execution riskMediumSafe, reliable plant operations and successful integration of bolt-on acquisitions are crucial for margin maintenance.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 364.35M USD
Price to earnings Ratio -
1Y Target Price 18
Price to earnings Ratio -
1Y Target Price 18
Volume (30-day avg) 309.3K shares
Beta 1.25
52 Weeks Range 12.67 - 26.00
Updated Date 11/20/2026
52 Weeks Range 12.67 - 26.00
Updated Date 11/20/2026
Dividends yield (FY) 4.55%
Basic EPS (TTM) -0.84

Sector & Industry Intelligence

Sector

Basic Materials

Caution
Sentiment
Bearish
Momentum
BUY Breadth Lower
BUY participation
18.9%
Active BUY / eligible
7 / 37
30-Day BUY Count Change
+1
Market state
Bearish

Qualifying BUY stocks have fallen well below recent levels and have not recovered.

Industry

Chemicals

BUY participation
100.0%
Active BUY / eligible
2 / 2
30-Day BUY Count Change
+1

Eligible universe: 2 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -26.78%
Avg. Invested days 30
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ASIX receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
ASIX has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, solid earnings growth (+11.6%) is partially offset by soft cash generation (FCF margin 0.4%), moderate revenue growth (+0.3%), soft profitability (net margin 3.2%).

Financial Health Rating

★★★★★
ASIX's financial health is supported by solid cash strength, including free-cash-flow generation (0.4% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is ASIX's strongest growth driver at +279.5% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+11.6%, solid) is also solid, while revenue growth (+0.3%, moderate) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 91.4% and approximately 96.6% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 3.15% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 9.04%
CastleKnight Management LP 5.89%
American Century Companies Inc 5.62%
Dimensional Fund Advisors, Inc. 5.31%
Aegis Financial Corporation 4.48%

Unit Economics (Per $1K Revenue)

★★★★★
ASIX generates approximately $114 of gross profit, $44 of operating income, and $4 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 1-star rating, with weak cash conversion and soft capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 9.45%

Quantitative Style Profile

★★★★★
ASIX has a liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Nylon & IntermediatesSale of caprolactam, nylon resins, and acetone into engineering plastics, fibers, and packaging markets.Provides industrial exposure to automotive, construction, and consumer goods manufacturing.
Plant NutrientsProduction and distribution of ammonium sulfate fertilizers and sulfur solutions to agricultural markets.Drives a major portion of revenues through global agricultural demand and crop nutrition needs.
Chemical IntermediatesAlkyl and specialty amines, chemical solvents, and electronic-grade products.Offers higher-margin niche exposure across paints, coatings, adhesives, and agrochemicals.
Geographic ExposurePrimarily domestic United States operations and export sales to international regions.Revenue is heavily anchored in North American industrial and agricultural supply chains.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 752.38M
Price to Sales(TTM) 0.23
Enterprise Value 752.38M
Price to Sales(TTM) 0.23
Enterprise Value to Revenue 0.48
Enterprise Value to EBITDA 11.42
Shares Outstanding 27.01M
Shares Floating 26.10M
Shares Outstanding 27.01M
Shares Floating 26.10M
Percent Insiders 3.15
Percent Institutions 91.36

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.